ES2188666T3 - Analogos de la distamicina utilies como agentes antitumorales o antivirales. - Google Patents

Analogos de la distamicina utilies como agentes antitumorales o antivirales.

Info

Publication number
ES2188666T3
ES2188666T3 ES95926927T ES95926927T ES2188666T3 ES 2188666 T3 ES2188666 T3 ES 2188666T3 ES 95926927 T ES95926927 T ES 95926927T ES 95926927 T ES95926927 T ES 95926927T ES 2188666 T3 ES2188666 T3 ES 2188666T3
Authority
ES
Spain
Prior art keywords
sup
group
instituted
sub
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95926927T
Other languages
English (en)
Inventor
Italo Beria
Enrico Pesenti
Laura Capolongo
Nicola Mongelli
Piergiovanni Baraldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of ES2188666T3 publication Critical patent/ES2188666T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nozzles For Spraying Of Liquid Fuel (AREA)
  • Gas Burners (AREA)
  • Pre-Mixing And Non-Premixing Gas Burner (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA (I) EN DONDE N ES 0 O 1; CADA X, Y, Z ES INDEPENDIENTEMENTE N O CH; A ES UN ANILLO HETEROMONOCICLICO PENTATOMICO INSUSTITUIDO O SUSTITUIDO POR UN GRUPO DE ALQUILO C{SUB,1-3}, B ES (A); (B); (C) O (D); Y AMBAS R{SUP,1} Y R{SUP,2} SON IGUALES Y SON AMBAS UN GRUPO DE ALQUILO C{SUB,1-6} INSUSTITUIDO O SUSTITUIDO POR HALOGENO O HIDROXI; O UNA DE R{SUP,1} Y R{SUP,2} ES HIDROGENO Y LA OTRA ES UN GRUPO (E) EN EL CUAL M ES CERO O UN ENTERO ENTRE 1 Y 4 Y R{SUP,4} ES UN GRUPO DE AZIRIDINILO; CICLOPROPILO; O UN GRUPO DE VINILO INSUSTITUIDO O SUSTITUIDO EN LA POSICION 1 O 2 POR HALOGENO O ALQUILO C{SUB,1-3}; UN GRUPO DE OXIRANILO INSUSTITUIDO O SUSTITUIDO EN LA POSICION 2 POR ALQUILO C{SUB,1-3} O HALOGENO; O UN GRUPO (F) EN DONDE R{SUP,5} Y R{SUP,6} SON AMBAS UN GRUPO DE ALQUILO C{SUB,1-6} INSUSTITUIDO O SUSTITUIDO POR HALOGENO O HIDROXI; TENIENDO EN CUENTA QUE A) CUANDO CADA UNA DE X, Y, Z ES CH, ENTONCES A NO ES TIOFENO O PIRROL INSUSTITUIDO O SUSTITUIDO POR UN GRUPO DE ALQUILO C{SUB,1-3}, Y B) CUANDO N ES 1 CADA X, Y, Z ES CH Y R{SUP,1} Y R{SUP,2} SON LO MISMO Y SON AMBAS 2CLOROETILO, ENTONCES A NO ES 1-METILIMIDIAZOL O TIAZOL; TAMBIEN SE PRESENTAN LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS COMPUESTOS. LOS COMPUESTOS DE LA INVENCION SON UTILES COMO AGENTES ANTITUMORALES O ANTIVIRALES.
ES95926927T 1994-08-08 1995-07-18 Analogos de la distamicina utilies como agentes antitumorales o antivirales. Expired - Lifetime ES2188666T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9416005A GB9416005D0 (en) 1994-08-08 1994-08-08 Peptidic compounds analogous to distamycin a and process for their preparation

Publications (1)

Publication Number Publication Date
ES2188666T3 true ES2188666T3 (es) 2003-07-01

Family

ID=10759569

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95926927T Expired - Lifetime ES2188666T3 (es) 1994-08-08 1995-07-18 Analogos de la distamicina utilies como agentes antitumorales o antivirales.

Country Status (19)

Country Link
US (1) US5753629A (es)
EP (1) EP0722446B1 (es)
JP (1) JPH09504039A (es)
KR (1) KR960704884A (es)
CN (1) CN1131946A (es)
AT (1) ATE229524T1 (es)
AU (1) AU689623B2 (es)
CA (1) CA2172629A1 (es)
DE (1) DE69529143T2 (es)
ES (1) ES2188666T3 (es)
FI (1) FI961506A7 (es)
GB (1) GB9416005D0 (es)
HU (1) HUT76267A (es)
IL (1) IL114794A0 (es)
NO (1) NO961377L (es)
NZ (1) NZ290404A (es)
PL (1) PL313821A1 (es)
WO (1) WO1996005196A1 (es)
ZA (1) ZA956590B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513759A (ja) 1996-02-26 2001-09-04 カリフォルニア・インスティチュート・オブ・テクノロジー 二本鎖ｄｎａの副溝において結合する改良されたポリアミド
US6635417B1 (en) 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
CN1260006A (zh) * 1996-02-26 2000-07-12 加利福尼亚州技术学院 双链dna和杂环低聚物之间复合物的形成
EP0973740A1 (en) * 1996-02-26 2000-01-26 California Institute Of Technology Design, synthesis and use of specific polyamide dna-binding ligands
WO1998045284A1 (en) 1996-02-26 1998-10-15 California Institute Of Technology Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
US6555692B1 (en) 1996-02-26 2003-04-29 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US6506906B1 (en) 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
US6143901A (en) * 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
GB9610079D0 (en) * 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9806689D0 (en) 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
US6384005B1 (en) * 1998-04-27 2002-05-07 Procter & Gamble Company Garment conditioning composition
GB9812211D0 (en) 1998-06-05 1998-08-05 Pharmacia & Upjohn Spa Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
ATE362940T1 (de) * 2000-03-16 2007-06-15 Genesoft Inc Geladene verbindungen mit einer nukleinsäure- bindenden einheit sowie deren verwendungen
US7078536B2 (en) * 2001-03-14 2006-07-18 Genesoft Pharmaceuticals, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015446D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
GB0029004D0 (en) 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
WO2002088119A1 (en) * 2001-04-26 2002-11-07 Genesoft Pharmaceuticals, Inc Halogen-substituted thienyl compounds
AU2002312370A1 (en) * 2001-06-13 2002-12-23 Roland W. Burli Antipathogenic benzamide compounds
US6825228B2 (en) 2001-06-13 2004-11-30 Genesoft Pharmaceuticals, Inc. Benzothiophene compounds having antiinfective activity
ITTO20010633A1 (it) 2001-07-02 2003-01-02 Univ Ferrara Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a.
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CA2494139A1 (en) 2002-08-02 2004-02-12 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
AU2003285958A1 (en) * 2002-10-25 2004-05-25 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
US7129214B2 (en) * 2002-12-10 2006-10-31 Oscient Pharmaceuticals Corporation Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
ATE410161T1 (de) * 2003-05-02 2008-10-15 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
JP2006525361A (ja) * 2003-05-02 2006-11-09 エラン ファーマシューティカルズ，インコーポレイテッド ブラジキニンｂ１受容体アンタゴニストとしての選択された置換ピラゾール誘導体および関連化合物
US20070161633A1 (en) * 2003-05-02 2007-07-12 Elan Pharmaceuticals, Inc. 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
GB0619325D0 (en) * 2006-09-30 2006-11-08 Univ Strathclyde New compounds
CN104845967B (zh) 2015-04-15 2020-12-11 苏州新海生物科技股份有限公司 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用
WO2018047148A1 (en) 2016-09-12 2018-03-15 Novartis Ag Compounds for the inhibition of mirna
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468642B (sv) * 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
IT1271456B (it) * 1993-03-01 1997-05-28 Menarini Farma Ind Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono
IT1263089B (it) * 1993-04-26 1996-07-24 Menarini Farma Ind Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.

Also Published As

Publication number Publication date
KR960704884A (ko) 1996-10-09
NO961377D0 (no) 1996-04-03
ZA956590B (en) 1996-03-18
DE69529143D1 (en) 2003-01-23
NO961377L (no) 1996-05-30
CN1131946A (zh) 1996-09-25
FI961506A0 (fi) 1996-04-03
EP0722446B1 (en) 2002-12-11
GB9416005D0 (en) 1994-09-28
JPH09504039A (ja) 1997-04-22
NZ290404A (en) 1997-04-24
FI961506A7 (fi) 1996-06-05
PL313821A1 (en) 1996-07-22
HU9601218D0 (en) 1996-07-29
HUT76267A (en) 1997-07-28
IL114794A0 (en) 1995-12-08
US5753629A (en) 1998-05-19
AU3113695A (en) 1996-03-07
AU689623B2 (en) 1998-04-02
WO1996005196A1 (en) 1996-02-22
MX9601250A (es) 1998-12-31
DE69529143T2 (de) 2003-09-11
EP0722446A1 (en) 1996-07-24
ATE229524T1 (de) 2002-12-15
CA2172629A1 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
ES2113368T3 (es) Antagonistas de serotonina.
ES2152207T3 (es) Derivados condensados de la purina.
ES2159760T3 (es) Derivados de aril purina y piridopirimidina y de heteroaril purina y piridopirimidina.
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
ES8505681A1 (es) Procedimiento para preparar n2-acil-9-(1, 3-dihidroxi-2-propoximetil)-guaninas y sus sales farmaceuticamente aceptables
ES2188584T3 (es) Derivados heterociclicos de amina.
ES2059491T3 (es) Derivados de indol con anillos condensados.
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ES2106616T3 (es) Derivados de 11,21-bisfenilo-19-nor-pregnanos.
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
ES2138977T3 (es) Agonistas muscarinicos.
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
ES2160237T3 (es) O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos.
ES2151192T3 (es) Compuestos de quinolina y quinazolina utiles en terapia.
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
ES2159758T3 (es) Nuevas n-aminoalquilfluorenocarboxamidas; una nueva clase de ligandos especificos a subtipos del receptor de la dopamina.
ES2153491T3 (es) Derivados de quinazolina.
ES2149468T3 (es) Derivados de radicicol.
ES2123873T3 (es) Pirrolocarbazol.
ES2183866T3 (es) Derivados de beta-aril y beta-heteroaril-alfa-cianoacrilamidas sustituido como inhibidors de la tirosina quinasa.
ES2076155T3 (es) Compuestos de piperidinilo.
ES2045044T3 (es) Derivados de sulfonamidolfenilo y agentes terapeuticos y preventivos de la arritmia que contienen los mismos.